av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

39.94

17/05 20:00

Market Cap

2.00B

Beta: 2.11

Volume Today

438.32K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-81.55M
-
-118.08M
44.79%
-127.20M
7.72%
-128.53M
1.05%
-93.03M
27.62%
-151.18M
62.51%
-50.88M
66.35%
-59.78M
17.50%
-70.51M
17.95%
-112.33M
59.30%
-141.43M
25.91%
depreciation and amortization
2.94M
-
3.40M
15.48%
4.01M
17.94%
4.09M
2.02%
5.31M
29.77%
3.80M
28.42%
4.86M
27.81%
3.93M
19.12%
3.07M
21.91%
2.90M
5.61%
3.01M
3.87%
deferred income tax
-1.39M
-
90K
106.49%
350K
288.89%
1.01M
187.71%
-24.28M
2,511.32%
-765K
96.85%
671K
187.71%
-1.17M
273.92%
-227K
80.55%
-227K
0%
-22.80M
9,945.37%
stock based compensation
4.55M
-
6.85M
50.66%
12.77M
86.43%
15.32M
19.91%
12.31M
19.62%
8.08M
34.36%
4.55M
43.68%
3.92M
13.97%
8.95M
128.68%
15.61M
74.37%
23.89M
53.03%
change in working capital
7.68M
-
6.13M
20.19%
10.89M
77.66%
-6.56M
160.26%
-12.21M
86.05%
-15.37M
25.95%
-4.32M
71.88%
-299K
93.08%
-1.05M
252.51%
-3.90M
269.83%
13.46M
445.36%
accounts receivables
-445K
-
62K
113.93%
-814K
-
-96K
88.21%
-777K
709.38%
-777K
0%
-787K
1.29%
1.57M
300%
-175K
111.12%
-2.28M
1,203.43%
inventory
611K
-
-687K
-
-3.57M
419.65%
1.78M
149.94%
13.89M
678.86%
accounts payables
7.24M
-
-4.97M
-
-8.74M
75.94%
-13.11M
49.93%
-13.11M
0%
1.64M
112.49%
3.65M
123.02%
3.12M
14.51%
9.38M
200.48%
other working capital
276K
-
6.07M
2,097.83%
10.89M
79.48%
-89K
100.82%
205K
330.34%
-3.27M
1,694.15%
-4.32M
32.28%
-1.15M
73.40%
-6.28M
446.17%
-6.85M
9.00%
6.36M
192.89%
other non cash items
97K
-
72K
25.77%
288K
300%
1.64M
468.75%
11.96M
630.46%
80.20M
570.32%
-1.29M
101.61%
13.00M
1,104.48%
-1.14M
108.76%
-5.79M
408.70%
16.58M
386.42%
net cash provided by operating activities
-67.67M
-
-101.54M
50.05%
-98.89M
2.61%
-113.04M
14.31%
-99.93M
11.59%
-75.23M
24.71%
-46.41M
38.31%
-40.40M
12.95%
-60.91M
50.75%
-103.73M
70.31%
-107.29M
3.43%
investments in property plant and equipment
-4.22M
-
-1.93M
54.28%
-4.88M
152.77%
-2.75M
43.58%
-1.79M
35.01%
-813K
54.53%
-731K
10.09%
-1.55M
112.31%
-1.25M
19.52%
-1.83M
46.36%
-1.82M
0.55%
acquisitions net
4.59M
-
1.79M
61.06%
20K
-
55K
175%
27K
50.91%
69K
155.56%
purchases of investments
-112.12M
-
-148.31M
32.28%
-206.41M
39.17%
-175.73M
14.86%
-170.98M
2.70%
-171.18M
0.12%
-95.38M
44.28%
-220.32M
130.99%
-389.88M
76.96%
-188.97M
51.53%
-424.56M
124.68%
sales maturities of investments
38.89M
-
109.23M
180.85%
161.09M
47.48%
242.79M
50.72%
219.24M
9.70%
201.47M
8.10%
113.17M
43.83%
123.60M
9.21%
174.95M
41.54%
280.67M
60.43%
320.60M
14.23%
other investing activites
21K
-
-1.79M
-
342K
119.13%
net cash used for investing activites
-77.42M
-
-41.01M
47.03%
-50.19M
22.38%
68.91M
237.29%
46.47M
32.56%
29.82M
35.84%
17.08M
42.72%
-98.22M
675.05%
-216.16M
120.08%
89.94M
141.61%
-105.78M
217.61%
debt repayment
-11.03M
-
-2.96M
-
common stock issued
295.70M
-
188.84M
-
13.95M
92.61%
51.02M
265.88%
29.02M
43.12%
16.25M
44.01%
170.79M
951.16%
269.89M
58.02%
4.08M
98.49%
218.46M
5,259.62%
common stock repurchased
dividends paid
other financing activites
4.93M
-
1.17M
76.25%
4.31M
268.15%
536K
87.57%
265K
50.56%
419K
58.11%
9K
97.85%
3.40M
37,633.33%
2.48M
27.00%
net cash used provided by financing activities
289.60M
-
1.17M
99.60%
193.15M
16,394.53%
14.48M
92.50%
51.29M
254.16%
29.44M
42.60%
16.26M
44.78%
171.23M
953.24%
272.37M
59.07%
4.08M
98.50%
218.46M
5,259.62%
effect of forex changes on cash
-3K
-
-5K
66.67%
15K
400%
net change in cash
144.50M
-
-141.38M
197.84%
44.09M
131.18%
-29.65M
167.25%
-2.17M
92.67%
-15.98M
635.30%
-13.08M
18.15%
32.60M
349.30%
-4.69M
114.39%
-9.71M
106.99%
5.38M
155.44%
cash at beginning of period
24.90M
-
169.40M
580.41%
28.02M
83.46%
72.11M
157.34%
42.46M
41.11%
40.29M
5.12%
24.31M
39.66%
11.23M
53.80%
43.84M
290.28%
39.14M
10.71%
29.43M
24.82%
cash at end of period
169.40M
-
28.02M
83.46%
72.11M
157.34%
42.46M
41.11%
40.29M
5.12%
24.31M
39.66%
11.23M
53.80%
43.84M
290.28%
39.14M
10.71%
29.43M
24.82%
34.81M
18.30%
operating cash flow
-67.67M
-
-101.54M
50.05%
-98.89M
2.61%
-113.04M
14.31%
-99.93M
11.59%
-75.23M
24.71%
-46.41M
38.31%
-40.40M
12.95%
-60.91M
50.75%
-103.73M
70.31%
-107.29M
3.43%
capital expenditure
-4.22M
-
-1.93M
54.28%
-4.88M
152.77%
-2.75M
43.58%
-1.79M
35.01%
-813K
54.53%
-731K
10.09%
-1.55M
112.31%
-1.25M
19.52%
-1.83M
46.36%
-1.82M
0.55%
free cash flow
-71.89M
-
-103.47M
43.93%
-103.76M
0.29%
-115.79M
11.59%
-101.72M
12.15%
-76.05M
25.24%
-47.15M
38.00%
-41.96M
11.01%
-62.16M
48.15%
-105.56M
69.83%
-109.11M
3.36%

All numbers in USD (except ratios and percentages)